Oral cromolyn therapy in patients with food allergy: a preliminary report
- PMID: 407817
Oral cromolyn therapy in patients with food allergy: a preliminary report
Abstract
In a preliminary double-blind, placebo controlled, crossover study, 10 out of 16 patients (62.5%) had remissions in acute symptoms of food allergy with oral cromolyn therapy. The effective dosage for each patient had to be sought individually. No serious side effects were encountered.